Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 25.40
+0.70 (2.83%)
Nov 13, 2026, 1:24 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 3.28 billion as of November 13, 2026. It is the 24,981st most valuable company in the world and the 1,308th biggest in Taiwan. Its market cap has decreased by 49.16% in one year.
Market Cap
3.28B
Enterprise Value
2.77B
Revenue
54.19M
Global Rank
Country Rank
#1,308 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has decreased from 4.86B to 3.28B, a decrease of -32.46%. That is a compound annual growth rate of -7.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 3.28B | -51.02% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BRIM Biotechnology | 3.80B |
| Sunhawk Vision Biotech | 3.69B |
| TWi Biotechnology | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.33B |
| Formosa Pharmaceuticals | 3.03B |
| Sagittarius Life Science | 3.03B |
| Shine-On BioMedical | 2.90B |
| BioGend Therapeutics | 2.76B |